RxDoctor Payments Data

Dorothy Ewen, NP

Family · Baker, LANPI 1639562515

Payments from drug & device makers

$4,396in general payments, 2019–2025

Across 271 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$681
  • Novo Nordisk$471
  • Amgen$392
  • Takeda Pharmaceuticals U.S.A., Inc.$309
  • GSK$182
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$4,382100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,396 in reported general payments places this provider in the 85th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$13,984
Medicare patients
47
Services billed
172

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide54$60,291
JardianceEmpagliflozin11$18,304
OzempicSemaglutide17$17,714
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$10,906
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,280
Olmesartan Medoxomil63$648
Rosuvastatin Calcium84$635
Levothyroxine Sodium70$599
Esomeprazole Magnesium20$565
Fluoxetine Hcl44$390
Bupropion XlBupropion Hcl18$329
Pantoprazole Sodium44$325
Potassium Chloride22$315
Montelukast Sodium21$257
Atorvastatin Calcium40$254

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$681$60,29154 claims
Boehringer IngelheimJardiance$116$18,30411 claims
Novo NordiskOzempic$471$17,71417 claims
GSKTrelegy Ellipta$182$10,90615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,610 family providers in Louisiana.

Other family in Baker

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →